Target intelligence / Profile preview

Karyopherin subunit alpha 3 (KPNA3)

Target
KPNA3
Molecular classification
Transporter, Nuclear transport protein, Karyopherin, Importin
01

Overview

Karyopherin subunit alpha 3 (KPNA3), commonly known as importin alpha-3, is a nuclear transport protein belonging to the importin alpha family, functioning as an adapter that recognizes nuclear localization signals (NLSs) on cargo proteins[2]. It forms a complex with importin beta (KPNB1), facilitating the translocation of large proteins through the nuclear pore complex in a Ran-dependent GTPase cycle[2]. KPNA3 is critically involved in the nuclear import of various proteins, including those implicated in neurodegenerative diseases. In the context of spinocerebellar ataxia type 3 (SCA3), KPNA3 mediates the import of polyglutamine-expanded ataxin-3, promoting its nuclear aggregation and toxicity, which are central to disease pathogenesis[1]. Experimental inhibition or knockdown of KPNA3 has been shown to rescue neurodegenerative phenotypes in in vivo models, highlighting its significance as a therapeutic target for disorders characterized by abnormal nuclear import and protein aggregation[1]. KPNA3 may play roles in infectious disease pathways and other disorders involving nucleocytoplasmic transport.

Other names
Importin subunit alpha-4IMA3Importin alpha-3Importin α3
02

Mechanism of action

Inhibition or modulation of KPNA3 can reduce abnormal nuclear import of disease-related proteins such as ataxin-3, alleviating toxicity and aggregation implicated in neurodegenerative diseases[1].

03

Biological functions

Nuclear protein importNuclear-cytoplasmic transportProtein localizationRegulation of gene expressionCellular compartmentalization
04

Disease associations

Neurodegenerative diseaseSpinocerebellar ataxia (specifically SCA3)Amyotrophic lateral sclerosis (ALS)Other
05

Safety considerations

Potential interference with normal nucleocytoplasmic transportpossible global disruption of protein localizationoff-target effects impacting normal cell viability and function[1]
06

Biomarkers

Nuclear localization of ataxin-3 in SCA3aggregate formation in neurons[1]

Beyond the preview

Go deeper on Karyopherin subunit alpha 3 (KPNA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Karyopherin subunit alpha 3 (KPNA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call